Mohapatra A, Saadeddin Z, Bertges DJ, Madigan MC, Al-Khoury GE, Makaroun MS, Eslami MH (2020) Nationwide trends in drug-coated balloon and drug-eluting stent utilization in the femoropopliteal arteries. J Vasc Surg 71(2):560–566. https://doi.org/10.1016/j.jvs.2019.05.034
Soga Y, Takahara M, Iida O, Tomoi Y, Kawasaki D, Tanaka A, Yamauchi Y, Tobita K, Kozuki A, Fujihara M, Ando K, Investigators P (2023) Vessel patency and associated factors of drug-coated balloon for femoropopliteal lesion. J Am Heart Assoc 12(1):e025677. https://doi.org/10.1161/JAHA.122.025677
Tepe G, Schnorr B, Albrecht T, Brechtel K, Claussen CD, Scheller B, Speck U, Zeller T (2015) Angioplasty of femoral-popliteal arteries with drug-coated balloons: 5-year follow-up of the THUNDER trial. JACC Cardiovasc Interv 8(1 Pt A):102–108. https://doi.org/10.1016/j.jcin.2014.07.023
Fujihara M, Takahara M, Soga Y, Iida O, Kawasaki D, Tomoi Y, Tsubakimoto Y, Ogata K, Karashima E, Kato T, Kobayashi Y, Kaneko N, Sasaki S, Ichihashi K (2023) Application of first-generation high- and low-dose drug-coated balloons to the femoropopliteal artery disease: a sub-analysis of the POPCORN registry. CVIR Endovasc 6(1):41. https://doi.org/10.1186/s42155-023-00390-x
Article PubMed PubMed Central Google Scholar
Kurata N, Iida O, Asai M, Okamoto S, Ishihara T, Nanto K, Tsujimura T, Hata Y, Toyoshima T, Higashino N, Mano T, Masai T, Higuchi Y (2025) Factors associated with recurrence after drug-coated balloon therapy for femoropopliteal in-stent restenosis. Heart Vessels 40(6):461–470. https://doi.org/10.1007/s00380-024-02487-2
Soga Y, Takahara M, Iida O, Kawasaki D, Tobita K, Fujihara M (2024) Clinical outcomes following low-dose second-generation “ranger” drug-coated balloon angioplasty for femoropopliteal artery disease. J Endovasc Ther. https://doi.org/10.1177/15266028241292464
Tataru DA, Lazar FL, Onea HL, Homorodean C, Ober MC, Olinic M, Spinu M, Olinic DM (2024) Benefits and challenges of drug-coated balloons in peripheral artery disease: from molecular mechanisms to clinical practice. Int J Mol Sci. https://doi.org/10.3390/ijms25168749
Article PubMed PubMed Central Google Scholar
Yoshikawa M, Torii S, Aihara K, Ito M, Nakamura N, Noda S, Yoshikawa A, Utsunomiya S, Nakazawa MdG, Ikari Y (2024) Differences in biologic drug effects and distal particulate embolization in three paclitaxel-coated balloons for femoropopliteal lesions in a rabbit model. J Endovasc Ther 31(6):1234–1243. https://doi.org/10.1177/15266028231161215
Kelsch B, Scheller B, Biedermann M, Clever YP, Schaffner S, Mahnkopf D, Speck U, Cremers B (2011) Dose response to Paclitaxel-coated balloon catheters in the porcine coronary overstretch and stent implantation model. Invest Radiol 46(4):255–263. https://doi.org/10.1097/RLI.0b013e31820577df
Article CAS PubMed Google Scholar
Ihara M, Nojima Y, Koh N, Adachi H, Kurimoto T, Okayama K, Sakata Y, Nanto S (2020) Distribution of paclitaxel particles after drug-coated balloon treatment - comparison between intravascular ultrasound images and electronic high-resolution angioscopy. Circ Rep 2(10):637–638. https://doi.org/10.1253/circrep.CR-20-0054
Article PubMed PubMed Central Google Scholar
Sakamoto T, Itoh T, Shimoda Y, Fusazaki T, Morino Y (2015) OCT visualization of the structure of intimal tissue after drug-eluting balloon deployment. JACC Cardiovasc Imaging 8(8):983–984. https://doi.org/10.1016/j.jcmg.2014.09.013
Suzuki S, Nakatani S, Sotomi Y, Shiojima I, Sakata Y, Higuchi Y (2020) Serial optical coherence tomography and angioscopic assessments of 10-year in-stent restenosis of Cypher sirolimus-eluting stent treated with drug-coated balloon angioplasty. J Int Med Res 48(1):300060519837445. https://doi.org/10.1177/0300060519837445
Villar-Matamoros E, Stokes L, Lloret A, Todd M, Tillman BW, Yazdani SK (2022) Understanding the mechanism of drug transfer and retention of drug-coated balloons. J Cardiovasc Pharmacol Ther 27:10742484221119560. https://doi.org/10.1177/10742484221119559
Article CAS PubMed PubMed Central Google Scholar
Ito R, Ishii H, Oshima S, Nakayama T, Sakakibara T, Kakuno M, Murohara T (2024) Clinical outcomes and risk factors associated with drug-coated balloon treatment for femoropopliteal artery disease in patients on maintenance hemodialysis. Heart Vessels 39(11):921–927. https://doi.org/10.1007/s00380-024-02416-3
Creel CJ, Lovich MA, Edelman ER (2000) Arterial paclitaxel distribution and deposition. Circ Res 86(8):879–884. https://doi.org/10.1161/01.res.86.8.879
Article CAS PubMed Google Scholar
Scheller B, Speck U, Abramjuk C, Bernhardt U, Böhm M, Nickenig G (2004) Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 110(7):810–814. https://doi.org/10.1161/01.CIR.0000138929.71660.E0
Article CAS PubMed Google Scholar
Kurata N, Iida O, Takahara M, Asai M, Masuda M, Okamoto S, Ishihara T, Nanto K, Kanda T, Tsujimura T, Matsuda Y, Hata Y, Mano T (2023) Clinical impact of the size of drug-coated balloon therapy on restenosis rate in femoropopliteal lesions. J Endovasc Ther 30(2):269–280. https://doi.org/10.1177/15266028221081082
Nichols AB, Smith R, Berke AD, Shlofmitz RA, Powers ER (1989) Importance of balloon size in coronary angioplasty. J Am Coll Cardiol 13(5):1094–1100. https://doi.org/10.1016/0735-1097(89)90267-2
Article CAS PubMed Google Scholar
Fujihara M, Takahara M, Sasaki S, Nanto K, Utsunomiya M, Iida O, Yokoi Y (2017) Angiographic dissection patterns and patency outcomes after balloon angioplasty for superficial femoral artery disease. J Endovasc Ther 24(3):367–375. https://doi.org/10.1177/1526602817698634
Jaffe R, Leung G, Munce NR, Thind AS, Leong-Poi H, Anderson KJ, Qi X, Trogadis J, Nadler A, Shiff D, Saperia J, Lockwood J, Jacobs C, Qiang B, Teitelbaum A, Dick AJ, Sparkes JD, Butany J, Wright GA, Strauss BH (2009) Natural history of experimental arterial chronic total occlusions. J Am Coll Cardiol 53(13):1148–1158. https://doi.org/10.1016/j.jacc.2008.09.064
Comments (0)